Select Page

Dr. Paul Fernyhough has been appointed Department Head of Pharmacology and Therapeutics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba for a five-year period, effective May 1, 2017.* Dr. Fernyhough was appointed as Acting Head in the Department of Pharmacology and Therapeutics on June 1, 2015.

Dr. Fernyhough has been Director for the Division of Neurodegenerative Disorders at St-Boniface Hospital Research since 2004, and is a professor in the Department of Pharmacology and Therapeutics and adjunct professor in the Department of Physiology & Pathophysiology.

Dr. Fernyhough was born and educated in East London, UK. He earned his B.Sc. degree in Biological Sciences at the University of Essex and a PhD in biochemistry in the department of Biochemistry (department of Sir Hans Krebs) at University of Sheffield (UK). He also completed postdoctoral research at Colorado State University, Kings College London (department of Maurice Wilkins) and as a Wellcome Trust Postdoctoral Fellow at St Bartholomew’s Medical College (department of Sir John Vane). (Drs Krebs, Wilkins and Vane are all Nobel Prize winners.)

His general research interest is in the cell biology underlying neurodegenerative disorders of the peripheral and central nervous systems.

*pending Board of Governors approval